Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of 21.80 million. The enterprise value is 91.98 million.
| Market Cap | 21.80M |
| Enterprise Value | 91.98M |
Important Dates
The next estimated earnings date is Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 22.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.85 |
| EV / Sales | 61.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.00 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.01 |
| Interest Coverage | -3.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -98.23% |
| Return on Capital (ROIC) | -251.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.96 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +666.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +666.87% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 49.80 |
| Average Volume (20 Days) | 5,352 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of 1.60 million and -32.28 million in losses. Loss per share was -5.24.
| Revenue | 1.60M |
| Gross Profit | 39,232 |
| Operating Income | -19.42M |
| Pretax Income | -32.28M |
| Net Income | -32.28M |
| EBITDA | -18.95M |
| EBIT | -19.42M |
| Loss Per Share | -5.24 |
Balance Sheet
The company has 322,736 in cash and 61.57 million in debt, giving a net cash position of -61.25 million.
| Cash & Cash Equivalents | 322,736 |
| Total Debt | 61.57M |
| Net Cash | -61.25M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -63.54M |
| Book Value Per Share | -12.52 |
| Working Capital | -18.26M |
Cash Flow
In the last 12 months, operating cash flow was -14.91 million and capital expenditures -426,367, giving a free cash flow of -15.34 million.
| Operating Cash Flow | -14.91M |
| Capital Expenditures | -426,367 |
| Free Cash Flow | -15.34M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 2.45% |
| Operating Margin | -1,213.93% |
| Pretax Margin | -2,018.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Conavi Medical has an Altman Z-Score of -37.27. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.27 |
| Piotroski F-Score | n/a |